These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 183514)

  • 1. Agonist and antimineralocorticoid activities of spirolactones.
    Sakauye C; Feldman D
    Am J Physiol; 1976 Jul; 231(1):93-7. PubMed ID: 183514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and antimineralocorticoid activities of spirolactones in toad bladder.
    Rossier BC; Claire M; Rafestin-Oblin ME; Geering K; Gäggeler HP; Corvol P
    Am J Physiol; 1983 Jan; 244(1):C24-31. PubMed ID: 6217754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone: a specific competitive antagonist of aldosterone in the toad bladder.
    Rossier BC; Geering K; Gäggeler HP; Claire M; Corvol P
    Am J Physiol; 1980 Nov; 239(5):F433-9. PubMed ID: 6776825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-induced protein synthesis in giant-toad (Bufo marinus) urinary bladders. Correlation with natriferic activity.
    Geheb M; Alvis R; Owen A; Hercker E; Cox M
    Biochem J; 1984 Feb; 218(1):221-8. PubMed ID: 6424655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone-induced protein in toad urinary bladder.
    Benjamin WB; Singer I
    Science; 1974 Oct; 186(4160):269-72. PubMed ID: 4212918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spirolactone inhibition of aldosterone induced nuclear RNA synthesis in toad urinary bladder.
    Hutchinson JH; Porter GA
    Res Commun Chem Pathol Pharmacol; 1970 May; 1(3):363-9. PubMed ID: 5002851
    [No Abstract]   [Full Text] [Related]  

  • 7. Mineralocorticoid-specificity of aldosterone-induced protein synthesis in giant-toad (Bufo marinus) urinary bladders.
    Geheb M; Alvis R; Hercker E; Cox M
    Biochem J; 1983 Jul; 214(1):29-35. PubMed ID: 6412695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone antagonism of aldosterone action on Na+ transport and RNA metabolism in toad bladder epithelium.
    Rossier BC; Wilce PA; Edelman IS
    J Membr Biol; 1977 Apr; 32(1-2):177-94. PubMed ID: 192893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mineralocorticoid antagonist activity of an 11 beta,18-oxidopregnane.
    Ulick S; Marver D; Adam WR; Funder JW
    Endocrinology; 1979 May; 104(5):1352-6. PubMed ID: 436780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hormone. Aldosterone antagonism in cultured epithelial cells.
    Pratt RD; Johnson JP
    Biochim Biophys Acta; 1984 Dec; 805(4):405-11. PubMed ID: 6239658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renal action of spirorenone and other 6 beta,7 beta; 15 beta,16 beta-dimethylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
    Casals-Stenzel J; Buse M; Wambach G; Losert W
    Arzneimittelforschung; 1984; 34(3):241-6. PubMed ID: 6329237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid activity of 19-nor-DOC and 19-OH-DOC in toad bladder.
    Perrone RD; Schwartz JH; Bengele HH; Dale SL; Melby JC; Alexander EA
    Am J Physiol; 1981 Nov; 241(5):E406-9. PubMed ID: 6795931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimineralocorticoid 11beta-substituted spirolactones exhibit androgen receptor agonistic activity: a structure function study.
    Nirdé P; Térouanne B; Gallais N; Sultan C; Auzou G
    Mol Pharmacol; 2001 May; 59(5):1307-13. PubMed ID: 11306716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modifications of anti-aldosterone compounds: effects on affinity of spirolactones for renal aldosterone receptors.
    Funder JW; Feldman D; Highland E; Edelman IS
    Biochem Pharmacol; 1974 May; 23(10):1493-501. PubMed ID: 4367952
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of corticoid agonists and antagonists on apical Na+ permeability of toad urinary bladder.
    Garty H; Peterson-Yantorno K; Asher C; Civian MM
    Am J Physiol; 1994 Jan; 266(1 Pt 2):F108-16. PubMed ID: 7508202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
    Losert W; Bittler D; Buse M; Casals-Stenzel J; Haberey M; Laurent H; Nickisch K; Schillinger E; Wiechert R
    Arzneimittelforschung; 1986 Nov; 36(11):1583-600. PubMed ID: 3028435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone receptor occupancy and sodium transport in the urinary bladder of Bufo marinus.
    Farman N; Kusch M; Edelman IS
    Am J Physiol; 1978 Sep; 235(3):C90-6. PubMed ID: 211853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structure-activity relationship study of spirolactones. Contribution of the cyclopropane ring to antimineralocorticoid activity.
    Chinn LJ; Salamon KW; Desai BN
    J Med Chem; 1981 Sep; 24(9):1103-7. PubMed ID: 6270335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of aldosterone-stimulated sodium transport by steroidal spirolactones.
    Porter GA
    Mol Pharmacol; 1968 May; 4(3):224-37. PubMed ID: 5661772
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of aldosterone on potassium transport in the toad bladder.
    Rodriguez HJ; Wiesmann WP; Klahr S
    Am J Physiol; 1975 Jul; 229(1):99-106. PubMed ID: 807117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.